Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Parkinson’s disease. Show all posts
Showing posts with label Parkinson’s disease. Show all posts
Wednesday, January 16, 2019

FDA Approves Inbrija (levodopa inhalation powder) for Intermittent Treatment of OFF Episodes in People with Parkinson’s Disease

›
In continuation of my update on Levodopa Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration approv...
Tuesday, November 5, 2013

Two forms of Parkinson's disease identified

›
A consortium of researchers, headed by a team from the Laboratoire CNRS d'Enzymologie et Biochimie Structurales, is well on the way to...
Saturday, November 24, 2012

CLR01 effectively inhibits synaptotoxicity in mice with Alzheimer's

›
We know that, aggregation of α-synuclein (α-syn) is implicated as being causative in the pathogenesis of Parkinson’s disease, multipl...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.